TK1 and hematopoietic and lymphoid cell neoplasm: Thus, TK1 shows good values in terms of diagnostic, prognostic and follow‐up performance in canine haematopoietic tumours, and therefore seems to be a good candidate as a biomarker in this field, despite a certain lack of specificity of this enzyme for other neoplastic pathologies.